| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |